Is This The Most Overlooked Gold Investment Strategy of 2024?

There is little debate on the potential of gold in the next year and decade. The real issue becomes - what's the best gold investment strategy today? Some investors are opting for a unique "royalty" alternative that outshines other options like holding gold bullion or investing in volatile mining stocks.

Read this stunning report on a little-known gold

ENZ Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 15.50%

Insider Buying (Last 12 Months): $29,370.00

Insider Selling (Last 12 Months): $0.00

Enzo Biochem Insider Trading History Chart

Enzo Biochem Share Price & Price History

^$1.27

▲ +0.06 (4.96%)

As of 12/8/2023 09:56 PM ET

Days: 30 | 90 | 365

Trading Experts Call It “The Perfect Tesla Trade”

From Wealthpress | Ad

Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.

Click here for details,

Enzo Biochem Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/13/2023	James G Wolf	Major Shareholder	Buy	5,000	$1.28	$6,400.00	4,100,000
2/10/2023	James G Wolf	Major Shareholder	Buy	5,000	$1.29	$6,450.00	4,095,000
1/27/2023	James G Wolf	Major Shareholder	Buy	11,800	$1.40	$16,520.00	4,090,000
11/23/2022	Hamid Erfanian	CEO	Buy	100,000	$1.97	$197,000.00	374,600
7/15/2022	Kara Cannon	COO	Buy	2,500	$2.42	$6,050.00	2,500
7/12/2022	Bradley Louis Radoff	Director	Buy	12,500	$2.27	$28,375.00	4,194,663
7/5/2022	Bradley Louis Radoff	Director	Buy	120,000	$2.20	$264,000.00	4,182,163
6/15/2022	Bradley Louis Radoff	Director	Buy	50,000	$2.21	$110,500.00	3,987,163
6/15/2022	Hamid Erfanian	CEO	Buy	4,600	$2.19	$10,074.00	274,600
6/14/2022	David Bench	CFO	Buy	3,500	$2.15	$7,525.00	6,000
3/16/2021	Discovery Fund Lp Harbert	Major Shareholder	Sell	444,768	$4.71	$2,094,857.28

Trading Experts Call It “The Perfect Tesla Trade”

From Wealthpress | Ad

Click here for details,

SEC Filings (Institutional Ownership Changes) for Enzo Biochem (NYSE:ENZ)

57.00% of Enzo Biochem stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Enzo Biochem Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/14/2023	Potomac Capital Management Inc.	1,455,000	$2.04M	2.6%	+38.6%	2.882%
11/6/2023	Assenagon Asset Management S.A.	81,197	$0.11M	0.0%	-55.4%	0.164%
8/15/2023	Corsair Capital Management L.P.	47,726	$88K	0.0%	-12.4%	0.096%
8/14/2023	Potomac Capital Management Inc.	1,049,900	$1.93M	2.0%	+34.5%	2.114%
8/14/2023	State Street Corp	167,039	$0.31M	0.0%	-9.3%	0.336%
8/11/2023	Renaissance Technologies LLC	2,704,864	$4.98M	0.0%	-2.4%	5.447%
8/11/2023	BlackRock Inc.	998,479	$1.84M	0.0%	-29.7%	2.011%
8/11/2023	Roumell Asset Management LLC	681,358	$1.25M	2.5%	-24.7%	1.372%
8/11/2023	Geode Capital Management LLC	337,575	$0.62M	0.0%	-4.9%	0.680%
8/9/2023	Dimensional Fund Advisors LP	1,267,075	$2.33M	0.0%	-16.7%	2.552%
8/3/2023	Fifth Lane Capital LP	85,000	$0.16M	0.0%	+54.9%	0.171%
7/31/2023	Agate Pass Investment Management LLC	16,292	$30K	0.0%	N/A	0.033%
7/25/2023	Assenagon Asset Management S.A.	181,862	$0.34M	0.0%	+138.6%	0.366%
7/24/2023	Sage Mountain Advisors LLC	23,362	$43K	0.0%	N/A	0.047%
5/16/2023	Susquehanna International Group LLP	18,643	$45K	0.0%	-34.0%	0.038%
5/16/2023	Jane Street Group LLC	27,023	$66K	0.0%	N/A	0.054%
5/16/2023	Snowden Capital Advisors LLC	22,499	$55K	0.0%	-22.7%	0.045%
5/15/2023	Cubist Systematic Strategies LLC	19,985	$49K	0.0%	N/A	0.040%
5/15/2023	Potomac Capital Management Inc.	780,509	$1.90M	2.0%	+37.2%	1.572%
5/15/2023	Roumell Asset Management LLC	905,312	$2.20M	5.0%	-57.5%	1.823%
5/12/2023	Renaissance Technologies LLC	2,770,064	$6.73M	0.0%	-1.6%	5.578%
5/12/2023	Corsair Capital Management L.P.	54,486	$0.13M	0.1%	-18.2%	0.110%
5/12/2023	BlackRock Inc.	1,420,388	$3.45M	0.0%	-0.4%	2.860%
5/12/2023	Mirabella Financial Services LLP	48,309	$13.62M	2.1%	N/A	0.097%
5/12/2023	Dimensional Fund Advisors LP	1,521,683	$3.70M	0.0%	-5.7%	3.064%
4/26/2023	IFG Advisory LLC	16,250	$39K	0.0%	N/A	0.033%
4/18/2023	Assenagon Asset Management S.A.	76,220	$0.19M	0.0%	N/A	0.153%
4/12/2023	FNY Investment Advisers LLC	11,003	$26K	0.0%	N/A	0.022%
2/15/2023	Morgan Stanley	367,302	$0.53M	0.0%	-5.6%	0.754%
2/14/2023	Susquehanna International Group LLP	28,228	$40K	0.0%	-189.6%	0.058%
2/13/2023	Renaissance Technologies LLC	2,813,964	$4.02M	0.0%	-3.3%	5.776%
2/13/2023	Fuller & Thaler Asset Management Inc.	983,285	$1.41M	0.0%	+1.3%	2.018%
2/9/2023	Dimensional Fund Advisors LP	1,614,450	$2.31M	0.0%	+1.3%	3.314%
11/15/2022	BlackRock Inc.	1,468,121	$3.28M	0.0%	-4.1%	3.013%
11/14/2022	Renaissance Technologies LLC	2,909,664	$6.49M	0.0%	-3.5%	5.972%
11/10/2022	Dimensional Fund Advisors LP	1,593,865	$3.55M	0.0%	-0.5%	3.271%
11/10/2022	Tower Research Capital LLC TRC	25,832	$57K	0.0%	-21.2%	0.053%
10/18/2022	Shulman DeMeo Asset Management LLC	15,487	$35K	0.0%	N/A	0.032%
8/18/2022	Goldman Sachs Group Inc.	21,122	$44K	0.0%	-27.2%	0.043%
8/16/2022	Prudential Financial Inc.	18,200	$38K	0.0%	N/A	0.037%
8/15/2022	State Street Corp	185,639	$0.38M	0.0%	-6.3%	0.381%
8/13/2022	Virtu Financial LLC	30,133	$62K	0.0%	N/A	0.062%
8/13/2022	Renaissance Technologies LLC	3,016,164	$6.24M	0.0%	+0.2%	6.191%
8/5/2022	Potomac Capital Management Inc.	559,500	$1.16M	1.3%	+12.6%	1.148%
8/3/2022	Potomac Capital Management Inc.	559,500	$1.16M	1.3%	+12.6%	1.148%
7/27/2022	Assenagon Asset Management S.A.	19,603	$41K	0.0%	N/A	0.040%
5/13/2022	Renaissance Technologies LLC	3,011,164	$8.73M	0.0%	-2.7%	6.182%
5/13/2022	Fuller & Thaler Asset Management Inc.	951,235	$2.76M	0.0%	+0.5%	1.953%
5/13/2022	Vanguard Group Inc.	1,770,749	$5.14M	0.0%	-0.7%	3.635%
5/12/2022	BlackRock Inc.	1,540,591	$4.47M	0.0%	+0.5%	3.163%
5/12/2022	SNS Financial Group LLC	62,500	$0.18M	0.0%	N/A	0.128%
5/11/2022	Bank of New York Mellon Corp	90,158	$0.26M	0.0%	+6.3%	0.185%
5/9/2022	Shufro Rose & Co. LLC	13,500	$39K	0.0%	N/A	0.028%
4/27/2022	Potomac Capital Management Inc.	496,805	$1.44M	1.2%	+138.8%	1.020%
4/26/2022	AMH Equity Ltd	30,000	$87K	0.1%	-95.0%	0.062%
2/15/2022	Corsair Capital Management L.P.	58,657	$0.19M	0.0%	N/A	0.121%
2/11/2022	Renaissance Technologies LLC	3,094,764	$9.93M	0.0%	-3.6%	6.385%
2/10/2022	Acadian Asset Management LLC	8,279	$26K	0.0%	N/A	0.017%
2/10/2022	Paradigm Financial Partners LLC	126,000	$0.41M	0.0%	+600.0%	0.260%
2/9/2022	Fuller & Thaler Asset Management Inc.	946,285	$3.04M	0.0%	+0.5%	1.952%
2/9/2022	Dimensional Fund Advisors LP	1,596,839	$5.13M	0.0%	+2.7%	3.294%
2/7/2022	Potomac Capital Management Inc.	208,000	$0.67M	0.6%	N/A	0.429%
1/24/2022	AMH Equity Ltd	596,742	$1.92M	2.7%	N/A	1.231%
1/21/2022	Agate Pass Investment Management LLC	24,292	$78K	0.0%	N/A	0.050%
11/16/2021	Two Sigma Advisers LP	193,100	$0.68M	0.0%	+459.7%	0.398%
11/16/2021	VIEX Capital Advisors LLC	1,510,401	$5.35M	3.2%	+0.8%	3.116%
11/15/2021	Neuberger Berman Group LLC	10,836	$38K	0.0%	N/A	0.022%
11/15/2021	Dimensional Fund Advisors LP	1,554,149	$5.50M	0.0%	-2.5%	3.206%
11/12/2021	Renaissance Technologies LLC	3,210,064	$11.36M	0.0%	-1.5%	6.623%
11/10/2021	Fuller & Thaler Asset Management Inc.	941,760	$3.33M	0.0%	-0.5%	1.943%
11/9/2021	BlackRock Inc.	1,532,170	$5.42M	0.0%	-1.2%	3.161%
11/2/2021	Raymond James & Associates	17,058	$60K	0.0%	N/A	0.035%
10/13/2021	Corrado Advisors LLC	19,366	$69K	0.0%	-15.6%	0.040%
8/25/2021	Marshall Wace LLP	28,909	$92K	0.0%	N/A	0.060%
8/17/2021	Millennium Management LLC	414,682	$1.32M	0.0%	+324.3%	0.856%
8/17/2021	Price T Rowe Associates Inc. MD	44,800	$0.14M	0.0%	-20.5%	0.092%
8/17/2021	Boothbay Fund Management LLC	13,900	$44K	0.0%	N/A	0.029%
8/17/2021	Bridgeway Capital Management LLC	221,200	$0.70M	0.0%	-14.5%	0.456%
8/16/2021	VIEX Capital Advisors LLC	1,498,902	$4.75M	3.4%	N/A	3.092%
8/16/2021	Charles Schwab Investment Management Inc.	13,471	$43K	0.0%	-87.3%	0.028%
8/16/2021	State Street Corp	195,354	$0.62M	0.0%	-75.5%	0.403%
8/16/2021	Tibra Equities Europe Ltd	111,000	$0.35M	0.1%	N/A	0.229%
8/16/2021	Marshall Wace LLP	28,909	$92K	0.0%	N/A	0.060%
8/13/2021	Renaissance Technologies LLC	3,259,264	$10.33M	0.0%	-2.4%	6.724%
8/13/2021	Northern Trust Corp	110,442	$0.35M	0.0%	-75.8%	0.228%
8/13/2021	Jump Financial LLC	39,000	$0.12M	0.0%	N/A	0.080%
8/13/2021	Geode Capital Management LLC	349,221	$1.11M	0.0%	-47.1%	0.720%
8/13/2021	Vanguard Group Inc.	2,010,296	$6.37M	0.0%	-15.7%	4.147%
8/13/2021	Fuller & Thaler Asset Management Inc.	946,185	$3M	0.0%	N/A	1.952%
8/12/2021	XTX Topco Ltd	14,737	$47K	0.0%	N/A	0.030%
8/12/2021	Dimensional Fund Advisors LP	1,594,061	$5.05M	0.0%	-2.4%	3.289%
8/12/2021	JPMorgan Chase & Co.	107,720	$0.34M	0.0%	-22.7%	0.222%
8/12/2021	Ergoteles LLC	192,900	$0.61M	0.0%	N/A	0.398%
8/11/2021	Bank of New York Mellon Corp	27,308	$87K	0.0%	-82.3%	0.056%
8/11/2021	BlackRock Inc.	1,550,385	$4.92M	0.0%	-60.3%	3.199%
8/9/2021	Cutter & CO Brokerage Inc.	25,827	$82K	0.0%	-13.4%	0.053%
8/3/2021	Evermore Global Advisors LLC	1,730,607	$5.49M	4.8%	-33.6%	3.570%
7/23/2021	Kempner Capital Management Inc.	25,475	$81K	0.0%	-73.3%	0.053%
5/19/2021	Squarepoint Ops LLC	102,282	$0.35M	0.0%	-39.6%	0.212%
5/18/2021	Millennium Management LLC	97,742	$0.34M	0.0%	+113.4%	0.203%

Data available starting January 2016

Enzo Biochem, Inc. develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. It also provides AMPIVIEW in situ hybridization probes for enhanced detection of low expressed targets useful in the growing spatial biology space; reagents and assays for cell and gene therapy research and development; POLYVIEW PLUS Enhanced Immunohistochemistry platform, offers solutions within the area of anatomical pathology through optimized assays; Enhanced Immunoassays, pushing sensitivity to expand immunoassay applications for basic research, bioprocess, and diagnostics; AMPIPROBE, a nucleic acid amplification platform; and Axxora.com, a proven distribution platform for original manufacturers of innovative research reagents. The company's proprietary products and technologies in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. It markets its products and services through its direct sales force and a network of distributors. The company was incorporated in 1976 and is headquartered in Farmingdale, New York.

Today's Range

Now: $1.27

$1.21

$1.28

50 Day Range

MA: $1.32

$1.21

$1.45

52 Week Range

Now: $1.27

$1.00

$2.74

Volume

60,400 shs

Average Volume

371,712 shs

Market Capitalization

$64.12 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.85

Who are the company insiders with the largest holdings of Enzo Biochem?: Enzo Biochem's top insider investors include:
Bradley Louis Radoff (Director)
James G Wolf (Major Shareholder)
Hamid Erfanian (CEO)
David Bench (CFO)
Kara Cannon (COO)
Learn More about top insider investors at Enzo Biochem.
Who are the major institutional investors of Enzo Biochem?: Enzo Biochem's top institutional shareholders include:
Potomac Capital Management Inc. — 2.88%
Assenagon Asset Management S.A. — 0.16%
Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Enzo Biochem stock.
Which institutional investors are selling Enzo Biochem stock?: Within the previous quarter, ENZ stock was sold by these institutional investors:
Assenagon Asset Management S.A.
Which institutional investors are buying Enzo Biochem stock?: In the previous quarter, ENZ stock was bought by institutional investors including:
Potomac Capital Management Inc.
In the last year, these company insiders have bought Enzo Biochem stock:
Bradley Louis Radoff (Director)
James G Wolf (Major Shareholder)
Hamid Erfanian (CEO)
David Bench (CFO)
Kara Cannon (COO)
Learn More investors buying Enzo Biochem stock.